4//SEC Filing
Warner Brent 4
Accession 0001209191-22-014372
CIK 0001661460other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:27 PM ET
Size
7.3 KB
Accession
0001209191-22-014372
Insider Transaction Report
Form 4
Warner Brent
President, Gene Therapy
Transactions
- Award
Common Stock
2022-03-01+307,881→ 307,881 total - Award
Stock Option (Right to Buy)
2022-03-01+431,034→ 431,034 totalExercise: $3.42Exp: 2032-02-29→ Common Stock (431,034 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's Inducement Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001910914
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:27 PM ET
- Size
- 7.3 KB